Welcome

The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.

Centers

MRC Protein Phosphorylation & Ubiquitylation Unit

The MRC Protein Phosphorylation and Ubiquitylation Unit (PPU) is a major research centre that focuses on the understanding of the biological roles of phosphorylation and ubiquitylation and how disruption of these processes cause human diseases such a...

View all

Partnerships

UCB Partners with Oxford University

UCB has entered into a research and development partnership with Oxford University in Neurology and Immunology areas. UCB will provide 3.6 million pounds to Oxford scientists over a period of three year to conduct research.

View all

Jobs

Sponsors

Eisai Eurofins Charles River Davos Pharma Ricerca Sigma-Aldrich AMRI Xenotech Xenotech HL HL Eisai Eurofins Charles River Davos Pharma Ricerca Sigma-Aldrich AMRI Xenotech Xenotech HL HL
View All